Phase II Multicenter Trial of Single Autologous Hematopo

Project: Research project

Project Details

Description

Phase II Multicenter Trial of Single Autologous Hematopoietic Cell Transplant Followed by Lenolidomide Maintenance for Multiple Myeloma with or without Vaccination with Dendritic Cell/Myeloma Fusions
StatusActive
Effective start/end date8/1/168/30/21

Funding

  • National Marrow Donor Program

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.